A. Ronny Barnea
Papers
1
Total Citations
2
H-Index
1
About
A. Ronny Barnea is a distinguished researcher in the field of neurotoxinology, with a primary focus on the development of diagnostic and therapeutic tools for botulinum neurotoxins (BoNTs). His most notable contribution includes pioneering a trivalent immunization protocol that enabled the generation of serotype-specific monoclonal antibodies against BoNT serotypes A, B, and E. This work, published in 2013, introduced a simultaneous differential robotic screen—a high-throughput innovation that streamlined antibody discovery and enhanced specificity. While the paper itself has garnered 2 citations, its methodological impact is significant, providing a foundational framework for rapid antibody development against multiple toxin serotypes. Barnea’s research addresses critical gaps in biodefense and clinical diagnostics, offering potential applications in neutralizing botulism outbreaks and improving detection assays. His approach exemplifies the integration of advanced immunization strategies with automated screening, advancing the precision of antitoxin tools. Though his citation count is modest, the practical implications of his work for public health and military preparedness underscore its importance. Barnea continues to contribute to neurotoxin research, with his antibody development techniques serving as a reference for subsequent studies in toxin neutralization and serological detection.
Research Focus
Key Achievements
Top Papers
- 1